Check the time stamp on this data. Updated AI-Generated Signals for Aligos Therapeutics Inc. (ALGS) available here: ALGS.

Proceeds expected to fund the start of the ALG-000184 Phase 2 clinical study Funding expected to extend cash runway into the second half of 2026 SOUTH SAN FRANCISCO, Calif., Feb. 12, 2025 (GLOBE ...

As of Feb. 4, there has been no official roster change—but change is inevitable. A big question mark hovers over TSM regarding their current roster, as all of their players and their coach have ...

Apex Legends developer Respawn Entertainment showcased their plans for the upcoming tournaments in the ALGS Year 5 roadmap.

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...

Game Designer John Larson discusses approaches to Legend and class changes, as well as how much of it is influenced by Apex Legends' esports league ...

SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a company specializing in therapies for liver and viral diseases with a current market capitalization of $96.58 million, announced today ...

Lead BR Designer Eric Canavese talks about the upcoming Apex Legends: Takeover season and what it means to buff every weapon ...

Apex Legends Season 24 features a plethora of weapon changes, all of which have been incorporated to shift the concrete gun ...

As each new season drops for Apex Legends, I pray to Respawn that it’ll be the one to bring the playerbase back around—and ...

EA’s recent earnings call gave us an insight into the development of Apex Legends. The team at Respawn Entertainment have ...

Pre-Market: 4:35:33 a.m. EST ...